Your browser is no longer supported. Please, upgrade your browser.
ClearPoint Neuro, Inc.
Index- P/E- EPS (ttm)-0.43 Insider Own2.10% Shs Outstand16.73M Perf Week-19.75%
Market Cap382.51M Forward P/E- EPS next Y-0.26 Insider Trans0.00% Shs Float12.52M Perf Month-14.24%
Income-6.80M PEG- EPS next Q-0.14 Inst Own10.90% Short Float2.59% Perf Quarter-1.54%
Sales12.80M P/S29.88 EPS this Y-1.60% Inst Trans100.35% Short Ratio0.66 Perf Half Y141.99%
Book/sh0.14 P/B123.07 EPS next Y50.00% ROA-27.70% Target Price- Perf Year390.88%
Cash/sh0.91 P/C19.03 EPS next 5Y30.00% ROE-409.40% 52W Range2.90 - 31.29 Perf YTD8.43%
Dividend- P/FCF- EPS past 5Y37.50% ROI-26.20% 52W High-44.33% Beta1.00
Dividend %- Quick Ratio6.90 Sales past 5Y22.80% Gross Margin71.10% 52W Low501.25% ATR1.84
Employees67 Current Ratio8.00 Sales Q/Q15.60% Oper. Margin-48.70% RSI (14)37.37 Volatility10.05% 9.72%
OptionableYes Debt/Eq0.00 EPS Q/Q12.70% Profit Margin-52.90% Rel Volume0.81 Prev Close17.23
ShortableYes LT Debt/Eq8.88 EarningsMar 04 AMC Payout- Avg Volume494.12K Price17.42
Recom2.00 SMA20-15.65% SMA50-20.99% SMA20044.67% Volume395,808 Change1.10%
Mar-18-21Initiated Lake Street Buy $32
Jul-17-20Initiated B. Riley FBR Buy $8
Apr-13-21 04:05PM  
Apr-06-21 04:05PM  
Mar-24-21 04:05PM  
Mar-12-21 12:21AM  
Mar-04-21 04:05PM  
Feb-23-21 04:05PM  
Feb-19-21 04:05PM  
Feb-18-21 10:10PM  
Feb-11-21 04:05PM  
Feb-05-21 08:00AM  
Feb-03-21 12:31PM  
Jan-28-21 12:30PM  
Jan-26-21 04:05PM  
Jan-22-21 04:30PM  
Jan-14-21 04:05PM  
Jan-12-21 04:05PM  
Dec-29-20 04:15PM  
Dec-28-20 12:13AM  
Dec-02-20 10:18AM  
Nov-30-20 09:15AM  
Nov-27-20 06:00AM  
Nov-17-20 03:52PM  
Nov-14-20 03:53PM  
Nov-13-20 05:41AM  
Nov-12-20 12:25PM  
Nov-10-20 04:05PM  
Nov-09-20 03:09PM  
Nov-04-20 04:05PM  
Oct-24-20 06:24PM  
Sep-14-20 04:15PM  
Aug-12-20 04:05PM  
Aug-06-20 08:00AM  
Jul-17-20 09:25AM  
May-12-20 04:05PM  
May-07-20 04:05PM  
Apr-17-20 08:10AM  
Apr-16-20 08:00AM  
Feb-14-20 08:55AM  
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for instruments or devices designed to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to perform minimally invasive surgical procedures in the heart. It has license and collaboration agreements with The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Microsystems, LLC, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Irvine, California.